Hepatocellular carcinoma
- PMID: 10217098
- DOI: 10.1016/S0140-6736(98)09148-X
Hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable. Hepatitis B and C exist only in man; the viruses have no known non-human reservoirs. Transmission of the viruses can be interrupted by vaccination against hepatitis B virus infection and improvements in medical techniques for hepatitis C, for which no vaccine has yet been developed.
Comment in
-
Hepatocellular carcinoma.Lancet. 1999 Jul 17;354(9174):253. doi: 10.1016/S0140-6736(05)66320-9. Lancet. 1999. PMID: 10421328 No abstract available.
-
Hepatocellular carcinoma.Lancet. 1999 Jul 17;354(9174):253. doi: 10.1016/s0140-6736(05)66322-2. Lancet. 1999. PMID: 10421329 No abstract available.
-
Hepatocellular carcinoma.Lancet. 1999 Jul 17;354(9174):253-4. doi: 10.1016/S0140-6736(05)66323-4. Lancet. 1999. PMID: 10421330 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical